Ma ke kahua o ka biopharmaceuticals, ʻo ke kūkulu ʻana i ka laina kelepona he hana paʻakikī a hoʻopau manawa, pili pono i ka pono a me ke kumukūʻai o ka noiʻi lāʻau a me ka hana ʻana.Ke hoʻomau nei ka ʻenehana i ka holomua, ke piʻi aʻe nei ka makemake no ka wikiwiki, pololei, a me ka paʻa o ka hoʻomohala laina kelepona.Ma ka pane ʻana i kēia pono, ua hoʻomohala maikaʻi ʻo Great Bay Bio i kahi AI-enabled Site-Specific Integration Cell Line Development Platform ʻaʻole wale i ka pōkole nui i ka pōʻai noiʻi a me ka hoʻomohala ʻana akā loaʻa pū kekahi i nā pae ʻike ʻole o ka hōʻike protein a me ke kūpaʻa.
Nā Manaʻo Kūikawā
Loaʻa wikiwiki i nā laina monoclonal hua kiʻekiʻe
ʻO ke kūkulu ʻia ʻana o ka laina kelepona maʻamau e pono ai nā mahina a i ʻole mau makahiki e hoʻopau ai.Hiki i ke kahua o Great Bay Bio, e hoʻohana ana i nā algorithms naʻauao a me nā mea hana, hiki ke loaʻa nā laina monoclonal kiʻekiʻe i nā mahina 1.5 wale nō.ʻO kēia manawa pono e hoʻolōʻihi i ka huakaʻi o ka lāʻau mai ka noiʻi a i ka mākeke, e lawe mai ana i nā loli kipi i ka ʻoihana.
Nā Papa Hōʻike Protein Kiʻekiʻe
I loko o nā biopharmaceuticals, ʻo nā pae hōʻike protein kahi mea nui.ʻO nā haʻahaʻa haʻahaʻa haʻahaʻa ʻoi aku ka nui o ka manawa a me ke kumukūʻai e koi ʻia e hana i ka nui o ka lāʻau lapaʻau.Hiki i ke kahua kūkulu laina kelepona o Great Bay Bio ke hoʻokō i nā pae hōʻike protein ma mua o 14g/L, e hoʻonui nui ana i ka hana hana.
100% Paʻa
Ma waho aʻe o ka wikiwiki a me ka maikaʻi, ʻo ke kūpaʻa kekahi mea koʻikoʻi no ka loiloi ʻana i kahi laina kelepona maikaʻi.Hiki i nā laina kelepona paʻa ke hana i nā pilikia i ka hana lōʻihi, e pili ana i ka maikaʻi a me ka nui o nā lāʻau lapaʻau.Hāʻawi ka paepae ʻo Great Bay Bio i ka 100% kūpaʻa, e hōʻoiaʻiʻo ana i ke kūlana kiʻekiʻe i ka wā o nā kaʻina hana nui.
Nā hiʻohiʻona noiʻi
ʻAʻole pono wale kēia AI-ʻa Site-Specific Integration Cell Line Development Platform i nā biopharmaceuticals akā pili pū kekahi i nā hoʻonohonoho ʻē aʻe e koi ai i nā kiʻekiʻe kiʻekiʻe o ka hōʻike protein, e like me nā antibody therapies, ka hoʻomohala ʻana i ke kanulau, a me ka bioengineering.ʻO kāna ākea ākea o nā noi noi e hoʻolilo i kēia kahua i kekahi o nā biotechnologies maikaʻi loa i loaʻa i kēia lā.
ʻO ka Great Bay Bio's AI-enabled Site-Specific Integration Cell Line Development Platform he mea kū hoʻokahi a maikaʻi hoʻi e lawe mai i nā hoʻololi epoch i ke kahua biopharmaceutical.Ma o kēia kahua, hiki ke hoʻopōkole nui ʻia nā pōʻai noiʻi a me ka hoʻomohala ʻana, ʻoiai hiki ke hoʻomaikaʻi ʻia ka maikaʻi o ka hana a me ka paʻa.E hoʻoikaika nui kēia i ka hoʻomohala ʻana i ka ʻoihana biopharmaceutical, e hāʻawi ana i nā poʻe i nā koho lapaʻau ʻoi aku ka wikiwiki, a ʻoi aku ka maikaʻi.
ʻAʻole ia he mea hoʻonui i ka ʻōlelo ʻana ua hiki i ka ʻenehana holomua o Great Bay Bio ke hoʻololi hou i ka ʻāina o ka ʻoihana biopharmaceutical e hiki mai ana, e hana nui i ke olakino a me ka maikaʻi o ke kanaka holoʻokoʻa.
Ka manawa hoʻouna: Sep-01-2023